S
Suresh V. Ambudkar
Researcher at National Institutes of Health
Publications - 288
Citations - 27038
Suresh V. Ambudkar is an academic researcher from National Institutes of Health. The author has contributed to research in topics: ATP-binding cassette transporter & P-glycoprotein. The author has an hindex of 74, co-authored 269 publications receiving 25158 citations. Previous affiliations of Suresh V. Ambudkar include Laboratory of Molecular Biology & University of Pittsburgh.
Papers
More filters
Journal ArticleDOI
A "Silent" Polymorphism in the MDR1 Gene Changes Substrate Specificity
Chava Kimchi-Sarfaty,Jung Mi Oh,In-Wha Kim,Zuben E. Sauna,Anna Maria Calcagno,Suresh V. Ambudkar,Michael M. Gottesman +6 more
TL;DR: It is hypothesized that the presence of a rare codon, marked by the synonymous polymorphism, affects the timing of cotranslational folding and insertion of P-gp into the membrane, thereby altering the structure of substrate and inhibitor interaction sites.
Journal ArticleDOI
Biochemical, cellular, and pharmacological aspects of the multidrug transporter
Suresh V. Ambudkar,Saibal Dey,Christine A. Hrycyna,Murali Ramachandra,Ira Pastan,Michael M. Gottesman +5 more
TL;DR: This review summarizes current research on the structure-function analysis of P-glycoprotein, its mechanism of action, and facts and speculations about its normal physiological role.
Biochemical, cellular, and pharmacological aspects of the multidrug
Suresh V. Ambudkar,Saibal Dey,Christine A. Hrycyna,Murali Ramachandra,Ira Pastan,Michael M. Gottesman +5 more
TL;DR: In this paper, a review summarizes current research on the structure-function analysis of P-glycoprotein, its mechanism of action, and facts and speculations about its normal physiological role.
Journal ArticleDOI
P-glycoprotein: from genomics to mechanism
TL;DR: A model for how ATP energizes transfer of substrates from these binding sites on P-gp to the outside of the cell is proposed, which accounts for the apparent stoichiometry of two ATPs hydrolysed per molecule of drug transported.
Journal ArticleDOI
Brca1 breast tumors contain distinct CD44+/CD24- and CD133+ cells with cancer stem cell characteristics
Mollie H. Wright,Anna Maria Calcagno,Crystal D. Salcido,Marisa D Carlson,Suresh V. Ambudkar,Lyuba Varticovski +5 more
TL;DR: Brca1-deficient mouse mammary tumors harbor heterogeneous cancer stem cell populations, and CD44+/CD24- cells represent a population that correlates with human breast cancer stem cells.